Synapse - Hematologic Malignancies, Division of

Results (13369)

In vitro stimulation with B7.1 transduced primary human T-ALL permits efficient generation of leukemia-selective allogeneic donor T cells expressing a mutant NGFR and HSV-TK for controlled graft-versus-leukemia reaction

Meeting Abstract

Koehne, G.; Gallardo, H. F.; Latouche, J. B.; Hirschberger, L.; Sadelain, M.; O'Reilly, R. J.
Blood (1999)

Fulltext@MSK | Save

In vivo expression of human glucose 6-phosphate deydrogenase (hG6PD) after retroviral-mediated transfer into murine and human hematopoietic stem cells (HSC)

Meeting Abstract

DeAngioletti, M.; Rovira, A.; Gallardo, H.; Rosti, V.; Camacho, O.; Notaro, R.; Liu, D.; Fein-Levy, C.; Sadelain, M.; Luzzatto, L.
Blood (1999)

Fulltext@MSK | Save

Langerhans cells generated from CD34+ hematopoietic progenitors achieve mature, costimulatory phenotype under serum-free conditions and stimulate potent cytolytic T lymphocyte responses against antigenic peptide

Meeting Abstract

Baggers, J.; Rodrigues, E.; Young, J. W.
Blood (1999)

Fulltext@MSK | Save

Factors predicting outcome in patients with primary refractory intermediate grade lymphoma (IGL) eligible for high dose chemoradiotherapy (HDT) and autologous stem cell transplant (ASCT)

Meeting Abstract

Kewalramani, T.; Hedrick, E. E.; Donnelly, G. B.; Satagopan, J. M.; Hunte, S.; Priovolos, A.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
Blood (1999)

Fulltext@MSK | Save

Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT)